Chief executives from the three largest pharmacy benefit managers (PBMs) steered around most of the difficult questions at a congressional hearing, repeatedly blaming rising prescription …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.